RCK- TIZIG RAYS OF HOPE TO CANCER PATIENTS
Fighting diseaseLocation
Kathmandu Nepal
Date
July, 2026-27
Beneficiaries
1
Rotarian Involvement
1
Non-Rotarian
0
Project Details
Club
Kasthamandap Kathmandu
Month
July
Fiscal Year
2026-27
Category
Fighting disease
Project Description
Cancer treatment is often extremely expensive, making life-saving medicines unaffordable for many patients and their families.
To address this challenge, Tizig Pharma, a Nepal-based pharmaceutical manufacturer, has signed a Memorandum of Understanding (MoU) with RC Kasthamandap (RCK) to support Nepali cancer patients by providing Tizig's oncology medicines at subsidized prices or, in deserving cases, free of cost upon the recommendation of RCK.
This partnership represents a significant step toward improving access to essential cancer treatment, reducing the financial burden on patients, and ensuring that more individuals receive timely care. Together, we are not only providing medicines—we are offering hope, dignity, and a greater chance of survival to cancer patients across Nepal.
To address this challenge, Tizig Pharma, a Nepal-based pharmaceutical manufacturer, has signed a Memorandum of Understanding (MoU) with RC Kasthamandap (RCK) to support Nepali cancer patients by providing Tizig's oncology medicines at subsidized prices or, in deserving cases, free of cost upon the recommendation of RCK.
This partnership represents a significant step toward improving access to essential cancer treatment, reducing the financial burden on patients, and ensuring that more individuals receive timely care. Together, we are not only providing medicines—we are offering hope, dignity, and a greater chance of survival to cancer patients across Nepal.
Project Costs
| Description | Amount (NPR) | '\\Cancer Treatment Medicine | Rs. 500,000.00 | 'Total | Rs. 500,000.00 |
|---|